Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: Preliminary results of a survival analysis

Annals of Surgical Oncology

Volumn 15, Issue 10, 2008, Pages 2701-2708

  Marcotte, Eric ^a   Sideris, Lucas ^a   Drolet, Pierre ^a   Mitchell, Andrew ^a   Frenette, Suzanne ^a   Leblanc, Guy ^a   Leclerc, Yves E ^a   Dubé, Pierre ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Appendiceal neoplasms; Hyperthermic intraperitoneal chemotherapy; Oxaliplatin; Peritoneal neoplasms

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; APPENDIX CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; MALE; OVERALL SURVIVAL; PERITONEUM CANCER; PROSPECTIVE STUDY; TREATMENT DURATION;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTINEOPLASTIC AGENTS; APPENDICEAL NEOPLASMS; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 51649099208     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0073-1     Document Type: Article

References (34)

1. ME McCusker TR Cote LX Clegg 2002 Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998 Cancer 94 3307 12
2. SJ Connor GB Hanna FA Frizelle 1998 Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies Dis Colon Rectum 41 75 80
3. BM Ronnett H Yan RJ Kurman 2001 Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis Cancer 92 85 91
4. RM Smeenk VJ Verwaal FA Zoetmulder 2007 Pseudomyxoma peritonei Cancer Treat Rev 33 138 45
5. DB Gough JH Donohue AJ Schutt 1994 Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach Ann Surg 219 112 9
6. TJ Miner J Shia DP Jaques 2005 Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy Ann Surg 241 300 8
7. JS Spratt RA Adcock M Muskovin 1980 Clinical delivery system for intraperitoneal hyperthermic chemotherapy Cancer Res 40 256 60
8. S Gonzalez-Moreno PH Sugarbaker 2004 Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding Br J Surg 91 304 11
9. D Elias S Laurent S Antoun 2003 Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy Gastroenterol Clin Biol 27 407 12
10. Z Guner U Schmidt MH Dahlke 2005 Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei Int J Colorectal Dis 20 155 60
11. R Loungnarath S Causeret N Bossard 2005 Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study Dis Colon Rectum 48 1372 9
12. EM Murphy R Sexton BJ Moran 2007 Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm Dis Colon Rectum 50 37 42
13. RM Smeenk VJ Verwaal N Antonini 2007 Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 104 9
14. JHt Stewart P Shen GB Russell 2006 Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy Ann Surg Oncol 13 624 34
15. PH Sugarbaker D Chang 1999 Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 727 31
16. TD Yan M Links ZY Xu 2006 Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms Br J Surg 93 1270 6
17. TD Yan D Black R Savady 2007 A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 14 484 92
18. D Baratti S Kusamura D Nonaka 2008 Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) Ann Surg Oncol 15 526 34
19. TD Yan L Bijelic PH Sugarbaker 2007 Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms Ann Surg Oncol 14 2289 99
20. PH Sugarbaker 2007 Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy Int J Hyperthermia 23 431 42
21. M Urano M Kuroda Y Nishimura 1999 For the clinical application of thermochemotherapy given at mild temperatures Int J Hyperthermia 15 79 107
22. G Los OA Smals MJ van Vugt 1992 A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity Cancer Res 52 1252 8
23. P Jacquet A Averbach AD Stephens 1998 Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies Oncology 55 130 8
24. RC Rietbroek PJ van de Vaart J Haveman 1997 Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells J Cancer Res Clin Oncol 123 6 12
25. D Elias M Bonnay JM Puizillou 2002 Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution Ann Oncol 13 267 72
26. D Elias L Sideris M Pocard 2004 Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients Ann Oncol 15 781 5
27. PH Sugarbaker 1998 Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis Semin Surg Oncol 14 254 61
28. PH Sugarbaker 1995 Peritonectomy procedures Ann Surg 221 29 42
29. P Jacquet PH Sugarbaker 1996 Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 359 74
30. D Dindo N Demartines PA Clavien 2004 Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 205 13
31. RM Smeenk VJ Verwaal FA Zoetmulder 2006 Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei-a report of 103 procedures Eur J Surg Oncol 32 186 90
32. PH Sugarbaker R Alderman G Edwards 2006 Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy Ann Surg Oncol 13 635 44
33. O Glehen F Mohamed PH Sugarbaker 2004 Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy Ann Surg 240 278 85
34. J Esquivel PH Sugarbaker 2001 Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients Ann Surg 234 198 205